Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNP-modified Tumor Cell Vaccine for Metastatic Tumors
NCT00722228Phase 2Recruiting
- Sponsor
- Hadassah Medical Organization
- Start
- Jul 2008
- Primary completion
- Mar 2025
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of M-Vax in melanoma, colorectal cancer (CRC), gastric cancer (GC), ovarian cancer, breast cancer, sponsored by Hadassah Medical Organization. Started Jul 2008; status: recruiting.
02
Drugs
M-Vax
03
Conditions
melanomacolorectal cancer (CRC)gastric cancer (GC)ovarian cancerbreast cancer
Beyond the preview
Go deeper on NCT00722228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722228.